首页> 中文期刊>药理与制药(英文) >Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan

Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan

     

摘要

[Background] Medical staff have many occasions to be exposed to anticancer drugs (ACDs) in the process of performing cancer chemotherapy. Although guidelines for the safe handling of ACDs have been published, actual measures against exposure to ACDs differ between hospitals, and no surveillance data regarding the conditions of each hospital in relation to performing chemotherapy in Japan are available. [Methods] To understand current measures against exposure to ACDs and problems related to cancer chemotherapy at outpatient departments, we conducted a questionnaire survey on doctors, pharmacists, and nurses in 10 leading hospitals for cancer chemotherapy in Japan. [Results] Responses were received from all 10 institutions. The hospital pharmacists prepared all ACDs for outpatients in each institution. All hospitals took basic measures against ACD exposure, such as using personal protective equipment and penetration-resistant waste containers. Conditions against exposure to ACDs generally improved between 2012 and 2015, especially in terms of conveyance of ACDs and use of a closed-system drug transfer device. However, no measures linking ACDs with administration routes or injection sites were commonly taken in any of the hospitals in 2015. [Conclusions] Conditions against ACD exposure improved between 2012 and 2015, possibly because new guidelines were issued. To improve measures for ACD exposure in Japan, preparing more appropriate manuals and offering more opportunities to medical staff for continuing education are considered important.

著录项

  • 来源
    《药理与制药(英文)》|2017年第5期|140-152|共13页
  • 作者单位

    Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan;

    Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan;

    Department of Internal Medicine, Fukuoka Wajiro Hospital, Fukuoka, Japan;

    Department of Pharmacy, Hamanomachi Hospital, Fukuoka, Japan;

    Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;

    Department of Pharmacy, Fukuoka University Hospital, Fukuoka, Japan;

    Department of Practical Pharmaceutical Science, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan;

    Division of Medical Oncology, Hematology, and Infection Diseases, Fukuoka University Hospital, Fukuoka, Japan;

    Department of Pharmacy, Kurume University Hospital, Fukuoka, Japan;

    Division of Gastroenterology, Kurume University Department of Medicine, Fukuoka, Japan;

    Department of Pharmacy, National Kyushu Cancer Center, Fukuoka, Japan;

    Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan;

    Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan;

    Department of Pharmacy, Saga-Ken Medical Centre Koseikan, Saga, Japan;

    Department of Medical Oncology, Saga-Ken Medical Centre Koseikan, Saga, Japan;

    Department of Pharmacy, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan;

    Department of Medicine and Comprehensive Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;

    Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan;

    Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    Exposure; Anticancer; Drugs; Measurement; Personal; Protective; Equipment; Outpatient; Service;

  • 入库时间 2022-08-21 01:24:27
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号